Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175672 | SCV000227205 | benign | not specified | 2015-10-08 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000331301 | SCV000399343 | likely benign | Brittle cornea syndrome 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001697170 | SCV000525861 | benign | not provided | 2018-06-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25564447) |
Labcorp Genetics |
RCV001697170 | SCV002409168 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000331301 | SCV002514284 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001697170 | SCV002563357 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | ZNF469: BP4, BS1, BS2 |
Genome Diagnostics Laboratory, |
RCV002277363 | SCV002565340 | benign | Ehlers-Danlos syndrome | 2022-01-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002326958 | SCV002631215 | benign | Cardiovascular phenotype | 2018-12-17 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001697170 | SCV005217559 | likely benign | not provided | criteria provided, single submitter | not provided |